Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00735150 · ClinicalTrials.gov registry record

Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk

A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
34
Enrollment target

NCT00735150: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00735150 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00735150 has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
34 participants
Enrollment target

Study Summary

We are inviting you to participate in a study of how people who have had genetic counseling for breast/ovarian cancer risk feel about certain reproductive technologies, preimplantation genetic diagnosis (PGD) and prenatal genetic diagnosis (PND), that may reduce the chances of passing increased risk onto one's children. We would also like feedback from patients who have been to our clinic in the past on the best ways to talk about PGD and PND during genetic counseling sessions. We are seeking both the opinions of people who are interested in these technologies and those who are not. It does not matter whether you have heard of PGD or PND before - you can still participate. Your past experience with genetic counseling is valuable to us in deciding how to communicate this information during sessions.

Interventions

  • BEHAVIORAL questionnaire, interview

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2008-03
Est. Completion 2010-10
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00735150 record still lists

NCT00735150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which questionnaire, interview is the first listed.

NCT00735150 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00735150 about?

NCT00735150 is a clinical study titled "Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk". We are inviting you to participate in a study of how people who have had genetic counseling for breast/ovarian cancer risk feel about certain reproductive technologies, preimplantation genetic diagnosis (PGD) and prenatal genetic diagnosis (PND), that may reduce the chances of passing increased risk...

What is the current status of trial NCT00735150?

This trial is currently completed. The enrollment target is 34 participants. The study started on 2008-03. Estimated completion is 2010-10.

What interventions are being tested in trial NCT00735150?

The interventions under investigation include: questionnaire, interview (BEHAVIORAL).

Who is sponsoring clinical trial NCT00735150?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00735150, the US trial registry maintained by the National Library of Medicine. NCT00735150 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.